As OpenAI prepares for public markets, its healthcare specific division, encompassing the consumer facing ChatGPT Health, the institutional ChatGPT for Healthcare and the practitioner-centric ChatGPT for Clinicians, faces unique clinical, economic and regulatory pressures. The following analysis outlines the pre- and post-IPO trajectory of OpenAI’s clinical ecosystem, providing ten highly structured predictions grounded in recent corporate, clinical, and regulatory developmen